Investigational Site Number : 2500007

Caen 14033

0 studies enrolling now · 2 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Plasma Cell Myeloma

Studies at this site

• A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant — Running, not enrolling
• Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) — Stopped early